Dr. Rana on Using Age at Diagnosis to Guide the Utility of Genetic Testing in Prostate Cancer
Huma Q. Rana, MD, MPH, discusses the use of age at diagnosis to guide the utility of genetic testing in men with prostate cancer.
Dr. Rana on Germline Genetic Testing in Advanced Prostate Cancer
Huma Q. Rana, MD, MPH, discusses germline genetic testing in men with advanced prostate cancer.
Later-Line Ruxolitinib Use Produces Ongoing Benefit in Real-World Patients With cGVHD
Orca-T Data With Survival, Tolerability Extends to Older Patients With Hematologic Cancers
Dr Ramdial on Gemcitabine/Clofarabine/Busulfan for Lymphoma Stem Cell Transplant
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies
2 Commerce Drive Cranbury, NJ 08512